Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub
Intravenous Fluid/Discontinued

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER

Clinical safety rating

caution

Comprehensive clinical and safety monograph for DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER (DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER).


Mechanism of Action

Dextrose is a monosaccharide that serves as a source of calories and water for hydration. It is metabolized to carbon dioxide and water, yielding energy. Ringer's solution provides electrolytes (sodium, chloride, potassium, calcium) to maintain fluid and electrolyte balance.

What the body does with it

MetabolismDextrose is metabolized via glycolysis and the citric acid cycle to carbon dioxide and water, yielding energy. Metabolism is insulin-dependent; in the presence of insulin, it is taken up by cells and phosphorylated to glucose-6-phosphate.
ExcretionRenal: dextrose is completely metabolized; no significant renal excretion of intact dextrose. Ringer's solution components (Na+, K+, Ca2+, Cl-) are primarily excreted renally, with >90% of infused ions eliminated unchanged in urine.
Half-lifeDextrose: not applicable as it is rapidly metabolized; exogenous dextrose has an elimination half-life of approximately 0.5-1 hour due to insulin-mediated uptake and metabolism. Electrolytes: no relevant half-life.
Protein bindingDextrose: negligible (<5%, not bound to proteins). Electrolytes: minimal protein binding (Na+, K+, Ca2+: <10% bound primarily to albumin for calcium).
Volume of DistributionDextrose: ~0.5 L/kg (total body water). Electrolytes: distribute into extracellular fluid (~0.2 L/kg).
BioavailabilityIntravenous: 100%.
Onset of ActionIntravenous: immediate (seconds to minutes) for volume expansion and correction of electrolyte imbalances; dextrose metabolism begins within minutes.
Duration of ActionIntravenous: effects on volume status last 1-2 hours depending on infusion rate; dextrose effect persists as long as infusion continues; electrolyte effects persist for duration of infusion plus renal excretion time.
Molecular Weight180.16

Classification & Brands

Dosing & administration

Intravenous infusion; dosing based on glucose requirements and fluid status. Typical adult dose: 500-1000 mL at 1-2 mL/min. Not to exceed 0.5 g/kg/h glucose.

Dosage formINJECTABLE
Renal impairmentNo specific dose adjustment. Use with caution in renal impairment due to potential fluid overload; monitor electrolytes and glucose.
Liver impairmentNo specific dose adjustment. Monitor glucose closely in severe hepatic impairment due to altered gluconeogenesis.
Pediatric useIntravenous infusion; initial rate 5-10 mL/kg, then titrate. Maximum glucose infusion rate: 0.2-0.3 g/kg/h for term infants.
Geriatric useUse lower initial infusion rates (0.5-1 mL/min) and monitor for fluid overload and hyperglycemia due to decreased renal function and glucose tolerance.

Use during pregnancy

1st trimesterDextrose 5% in Ringer's solution is generally considered safe in the first trimester when used for appropriate indications such as fluid and electrolyte replacement. No known teratogenic effects.
2nd trimesterSafe for use in the second trimester for fluid and electrolyte maintenance. Monitor blood glucose in patients with gestational diabetes.
3rd trimesterSafe for use in the third trimester; may be used for hydration and to prevent ketosis during labor. Caution in preeclampsia due to potential fluid overload.

Clinical note

Comprehensive clinical and safety monograph for DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER (DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER).

Placental transferDextrose crosses the placenta via facilitated diffusion; electrolytes cross via active transport. The solution components are physiologically regulated; no known harm at normal therapeutic doses.
BreastfeedingDextrose and electrolytes are normal constituents of breast milk; administration does not pose significant risk to the nursing infant. Use with caution in mothers with diabetes as it may affect maternal blood glucose levels.
Lactation RatingL1 (Compatible)
Teratogenic RiskDextrose 5% in Ringer's solution is not teratogenic. Dextrose is a physiologic sugar; Ringer's solution contains electrolytes at concentrations similar to plasma. No fetal risks are reported from IV administration at standard doses. Excessive dextrose may cause maternal hyperglycemia, which can lead to fetal macrosomia and neonatal hypoglycemia, but this is not teratogenic.
Fetal MonitoringMonitor maternal blood glucose levels, especially in gestational diabetes. Assess fluid balance for signs of overload (edema, pulmonary congestion). In prolonged infusion, monitor serum electrolytes.
Fertility EffectsNo known effects on fertility. Dextrose and Ringer's solution are physiologic and do not impair reproductive function.

Warnings & precautions

■ FDA Black Box Warning

None

Side Effect Profile

Serious Effects

Absolute Contraindications

Hyperglycemia (severe)Hypersensitivity to any componentDiabetic coma (unless treated with insulin)HypernatremiaFluid overloadSevere metabolic alkalosisAnuria secondary to renal failure

Clinical Precautions

PrecautionsUse with caution in patients with hyperglycemia, diabetes mellitus, or glucose intolerance, Monitor serum electrolytes, fluid balance, and blood glucose levels, Risk of fluid overload in patients with cardiac or renal impairment, May cause hyperglycemia, hyperosmolality, and osmotic diuresis, Not for use in patients with intracranial hemorrhage or hepatic coma
Food/DietaryNo specific food interactions. However, monitor glucose intake in diabetic patients. Avoid concurrent administration with blood products.

Clinical Tips & Counseling

Clinical PearlsThis solution provides 170 calories per liter from dextrose. Use within 24 hours of spiking the IV set. Do not administer simultaneously with blood products through the same line due to risk of hemolysis and aggregation. Monitor serum glucose in diabetic patients.
Patient AdviceThis IV solution provides fluids and sugar to help maintain your body's energy levels. · Report any signs of allergic reaction, such as rash, itching, or difficulty breathing. · Inform your healthcare provider if you have diabetes, kidney problems, or heart failure. · The solution may cause temporary increase in blood sugar levels.

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER Interactions

Loading safety data…

This overview is compiled from peer-reviewed clinical sources and FDA labeling. It's here to support — not replace — clinical judgment. Always verify dosing against your institution's current protocols before prescribing.

On this page

Mechanism of ActionDosing & administrationUse during pregnancyWarnings & precautionsDrug interactions

Compare with

DEXTROSE 10% IN PLASTIC CONTAINERDEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINERDEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINERDEXTROSE 5% IN PLASTIC CONTAINERDEXTROSE 7.7% IN PLASTIC CONTAINER

External sources

DailyMed (NIH) PubMed OpenFDA